SCHEMBL6199730

SCHEMBL6199730

CCCOc1ccccc1-c1nc2c(c(C)nn2Cc2ccccn2)c(=O)[nH]1

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 20/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7299809 0.88 PDE5A (1.00) PDE5A
SCHEMBL7302334 0.87 PDE5A (0.88) PDE5A
SCHEMBL7348770 0.86 PDE5A (1.00) PDE5A
SCHEMBL6193961 0.85 PDE5A (0.59) PDE5A
SCHEMBL7296916 0.85 PDE5A (0.83) PDE5A
SCHEMBL7308957 0.83 PDE5A (1.00) PDE5A
SCHEMBL6197841 0.82 PDE5A (0.71) PDE5A
SCHEMBL7299762 0.82 PDE5A (1.00) PDE5A
SCHEMBL6197035 0.82 PDE5A (0.70) PDE5A
SCHEMBL6338375 0.80 PDE5A (0.68) PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0995751-B1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER (US) 2005-06-29 EP disclosed
US-6407114-B1 BENIGN PROSTATIC HYPERPLASIA, CARDIOVASCULAR, GASTROINTESTINAL AND RESPIRATORY DISORDER TREATMENT; ANTIASTHMATIC, ANTIALLERGEN, AND ANTIDIABETIC AGENTS PFIZER INC. 2002-06-18 US disclosed
EP-0995751-A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. (US) 2000-04-26 EP disclosed
EP-0636626-A1 Pyrazolopyrimidine Derivatives LABORATOIRES GLAXO SA (FR) 1995-02-01 EP disclosed